Search - tctmd.com

Displaying 421 - 440 of 1897

Sort: Relevancy | Date

News Daily News

Study Supports Multiarterial CABG for Multivessel CAD

Todd Neale

September 24, 2015

News Daily News

在已有侵入性策略安排的NSTE-ACS患者中，上游比伐卢定的效果最好

L.A. McKeown

September 21, 2015

News Daily News

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

L.A. McKeown

September 21, 2015

News Daily News

Bivalirudina Upstream en Pacientes SCASEST resulta Óptima Con Estrategia Invasiva Programada

L.A. McKeown

September 21, 2015

Presentation

Impact of Anticoagulation Regimen Prior toRevascularization in Patients With NSTE-ACS

Presenter: Tobias Geisler

September 18, 2015

News Daily News

一项登记研究发现与药物治疗和冠状动脉搭桥术相比，CTO PCI可改善生存率

September 17, 2015

News Daily News

Un Estudio de Registro Vincula las PCI por OTC a una Mejor Supervivencia vs. Tratamiento Médico y CABG

September 17, 2015

News Daily News

Registry Study Links CTO PCI to Improved Survival vs Medical Therapy, CABG

September 17, 2015

News Industry News

Medtronic Launches Arc(TM) Support Catheter Series in U.S. for Treatment of Acute Ischemic Stroke

September 17, 2015

News Daily News

High Restenosis Rate After CTO Bailout Technique Linked to Suboptimal Flow

September 15, 2015

News Daily News

El Alto Índice de Reestenosis Post-Técnica de Rescate de una OTC se asocia a un Flujo Subóptimo

September 15, 2015

News Daily News

CTO 救助技术后再狭窄率高与血流不理想有关

September 15, 2015

News Industry News

First Patient Enrolled in CeloNova’s e-COBRA Clinical Registry

September 14, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Daily News

COURAGE 分析：运动能力较低的患者不太可能从血运重建中获益

L.A. McKeown

September 09, 2015

News Daily News

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

L.A. McKeown

September 09, 2015

News Industry News

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI

September 09, 2015

News Daily News

Análisis del COURAGE: Los Pacientes con una Menor Capacidad de Hacer Ejercicio No son Más Propensos a Beneficiarse de la Revascularización

L.A. McKeown

September 09, 2015

News Conference News ESC 2015

PRESERVATION I: Bioabsorbable Cardiac Matrix Does Not Benefit STEMI Patients

Yael L. Maxwell

September 02, 2015

News Conference News ESC 2015

PLATFORM: More Than 60% of Planned Catheterizations Cancelled When CT-Derived FFR Guides Care

L.A. McKeown

September 02, 2015

Advertisement

Study Supports Multiarterial CABG for Multivessel CAD

在已有侵入性策略安排的NSTE-ACS患者中，上游比伐卢定的效果最好

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

Bivalirudina Upstream en Pacientes SCASEST resulta Óptima Con Estrategia Invasiva Programada

Impact of Anticoagulation Regimen Prior toRevascularization in Patients With NSTE-ACS

一项登记研究发现与药物治疗和冠状动脉搭桥术相比，CTO PCI可改善生存率

Un Estudio de Registro Vincula las PCI por OTC a una Mejor Supervivencia vs. Tratamiento Médico y CABG

Registry Study Links CTO PCI to Improved Survival vs Medical Therapy, CABG

Medtronic Launches Arc(TM) Support Catheter Series in U.S. for Treatment of Acute Ischemic Stroke

High Restenosis Rate After CTO Bailout Technique Linked to Suboptimal Flow

El Alto Índice de Reestenosis Post-Técnica de Rescate de una OTC se asocia a un Flujo Subóptimo

CTO 救助技术后再狭窄率高与血流不理想有关

First Patient Enrolled in CeloNova’s e-COBRA Clinical Registry

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

COURAGE 分析：运动能力较低的患者不太可能从血运重建中获益

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI

Análisis del COURAGE: Los Pacientes con una Menor Capacidad de Hacer Ejercicio No son Más Propensos a Beneficiarse de la Revascularización

PRESERVATION I: Bioabsorbable Cardiac Matrix Does Not Benefit STEMI Patients

PLATFORM: More Than 60% of Planned Catheterizations Cancelled When CT-Derived FFR Guides Care

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content